Clinical Trials on 局部晚期乳腺癌 (LABC) in China
总计2032个结果
-
Fudan UniversityThe First Affiliated Hospital with Nanjing Medical University; Hubei Cancer Hospital; Ruijin Hospital 和其他合作者未知
-
Wuhan YZY Biopharma Co., Ltd.主动,不招人
-
Sun Yat-sen UniversityAkeso; Haplox Biotechnology Co., Ltd.招聘中
-
Antengene Therapeutics LimitedMerck Sharp & Dohme LLC招聘中
-
Zhejiang Cancer Hospital未知
-
Puma Biotechnology, Inc.完全的乳腺肿瘤 | 晚期乳腺癌 | 晚期恶性实体瘤美国, 比利时, 中国, 香港, 加拿大, 大韩民国, 印度, 波兰, 乌克兰
-
AstraZeneca完全的局部晚期或转移性 EGFR(+) NSCLC 患者中国
-
First Affiliated Hospital of Zhejiang UniversityZhejiang Cancer Hospital; First Affiliated Hospital of Wenzhou Medical University招聘中
-
The First Affiliated Hospital of Xiamen University未知
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.未知
-
Bliss Biopharmaceutical (Hangzhou) Co., Ltd主动,不招人
-
Sun Yat-sen UniversityShanghai Junshi Bioscience Co., Ltd.主动,不招人
-
Sun Yat-sen University主动,不招人
-
Shanghai Miracogen Inc.招聘中
-
Jiangsu Healthy Life Innovation Medical Technology...尚未招聘
-
Jiangsu Simcere Pharmaceutical Co., Ltd.Shanghai Xianxiang Medical Technology Co., Ltd.; Simcere Zaiming招聘中
-
Jiangsu Aosaikang Pharmaceutical Co., Ltd.招聘中
-
Chongqing University Cancer HospitalAkeso Pharmaceuticals, Inc.招聘中
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversitySun Yat-sen University; First People's Hospital of Foshan未知
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...招聘中